Study of clinicopathology and molecular biology on small-cell lung carcinoma

Study of clinicopathology and molecular biology on small-cell lung carcinoma - Pathological and molecular analysis of small-cell lung carcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010117

Enrollment

Registered

2013-02-25

Start date

2013-02-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

small-cell lung carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) The patients with histologically confirmed small-cell lung carcinoma resected surgically in the institutes affiliated with Fukushima Lung Cancer Study Group and/or Hokkaido Lung Cancer Clinical Study Group, and other cooperation hospitals from Jan. 2003 through Jan. 2013. 2) Patient consent for use of surgically resected specimen

Exclusion criteria

Exclusion criteria: 1) Histologically undiagnosed disease 2) Specimen resected surgically in the institutes that are not affiliated either with Fukushima Lung Cancer Study Group/Hokkaido Lung Cancer Clinical Study Group or our cooperation hospital network 3) Surgical specimen that was not obtained from Jan. 2003 through Jan. 2013. 4) In the case that the patient consent for use of surgically resected specimen is not obtained

Design outcomes

Primary

Measure	Time frame
To clarify the clinicopathological and molecular factors related to prognosis and druggable target	—

Countries

Japan

Contacts

Public ContactHiroshi Yokouchi

Fukushima Medical University, School of Medicine Department of Pulmonary Medicine

hyokouch@gmail.com024-547-1360

Outcome results